Evaluation of the Responsiveness of the SarQoL® Questionnaire, a Patient-Reported Outcome Measure Specific to Sarcopenia

被引:25
|
作者
Geerinck, Anton [1 ]
Bruyere, Olivier [1 ]
Locquet, Medea [1 ]
Reginster, Jean-Yves [1 ]
Beaudart, Charlotte [1 ]
机构
[1] Univ Liege, Dept Publ Hlth Epidemiol & Hlth Econ, Liege, Belgium
关键词
Older people; Patient-reported outcome measure; Psychometrics; Quality of life; Questionnaire; Responsiveness; Sarcopenia; QUALITY-OF-LIFE; HEALTH-STATUS; CONSENSUS; DISEASE; COSMIN; SF-36;
D O I
10.1007/s12325-018-0820-z
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
IntroductionThe Sarcopenia Quality of Life (SarQoL((R))) questionnaire was developed to provide a patient-reported outcome measure specific to sarcopenia. Its psychometric properties indicate that it is a valid and reliable instrument. However, until now, its ability to detect change over time has not been examined. Therefore, the objective of this study is to evaluate the responsiveness (also known as sensitivity to change) of the SarQoL((R)) questionnaire in a prospective, longitudinal cohort of community-dwelling, older, sarcopenic subjects.MethodsSarcopenic subjects from the SarcoPhAge (Sarcopenia and Physical impairment with advancing Age) study were included. Responsiveness was evaluated with nine pre-specified hypotheses on the correlation between the evolution of the SarQoL((R)) scores after a 2-year interval and the evolution of the scores on the Short Form-36 (SF-36) and the Euroqol 5-dimension (EQ-5D) questionnaires. This technique considers responsiveness to be a form of longitudinal validity. Additionally, standardized response means were also calculated to compare the quantity of change measured by the different questionnaires.ResultsA total of 42 sarcopenic subjects were included. The median age of the sample was 72.9 (68.9-78.8)years, 59.5% were female, and the mean body mass index was 23.3 (20.4-25.7)kg/m(2). A good responsiveness was observed, as evidenced by the confirmation of eight out of nine hypotheses, well above the 75% confirmation threshold. The standardized response mean of the Overall SarQoL((R)) score was significantly higher than those of the SF-36 Physical Component Summary (p=0.005), the EQ-5D Utility Index (p<0.001) and the Euroqol visual analogue scale (p=0.003).ConclusionThe first data available on the ability of the SarQoL((R)) questionnaire to detect change over time indicates that the questionnaire has good responsiveness. This, together with the previously established psychometric properties, confirms that the SarQoL((R)) questionnaire is a relevant instrument for the assessment of quality of life in sarcopenic populations.
引用
收藏
页码:1842 / 1858
页数:17
相关论文
共 50 条
  • [1] Evaluation of the Responsiveness of the SarQoL® Questionnaire, a Patient-Reported Outcome Measure Specific to Sarcopenia
    Anton Geerinck
    Olivier Bruyère
    Médéa Locquet
    Jean-Yves Reginster
    Charlotte Beaudart
    [J]. Advances in Therapy, 2018, 35 : 1842 - 1858
  • [2] Evaluation of Ankylosing Spondylitis Quality of Life questionnaire: responsiveness of a new patient-reported outcome measure
    Packham, Jon C.
    Jordan, Kelvin P.
    Haywood, Kirstie L.
    Garratt, Andrew M.
    Healey, Emma L.
    [J]. RHEUMATOLOGY, 2012, 51 (04) : 707 - 714
  • [3] Development of a New Patient-Reported Outcome Measure in Sarcopenia
    Evans, Christopher J.
    Chiou, Chiun-Fang
    Fitzgerald, Kristina A.
    Evans, William J.
    Ferrell, Betty R.
    Dale, William
    Fried, Linda P.
    Gandra, Shravanthi R.
    Dennee-Sommers, Brooke
    Patrick, Donald L.
    [J]. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2011, 12 (03) : 226 - 233
  • [4] Responsiveness of the Patient-Reported Outcome Measure for Vascular Malformation Questionnaire in Patients with Low-Flow Vascular Malformations
    Ring, Natalie Y.
    England, Ryan W.
    Motaghi, Mina
    Garg, Tushar
    Gong, Anna J.
    Gullotti, David M.
    Khalil, Adham
    Bailey, Christopher R.
    Grossberg, Anna L.
    Wu, Albert W.
    Weiss, Clifford R.
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2023, 34 (05) : 840 - 848.e5
  • [5] DEVELOPMENT OF HYPERTENSION-SPECIFIC PATIENT-REPORTED OUTCOME MEASURE. HYPERTENSION IMPACT QUESTIONNAIRE (HYPE)
    Ionov, M.
    Dubinina, E.
    Zvartau, N.
    Konradi, A.
    [J]. JOURNAL OF HYPERTENSION, 2019, 37 : E250 - E250
  • [6] Choosing a patient-reported outcome measure
    McClimans, Leah M.
    Browne, John
    [J]. THEORETICAL MEDICINE AND BIOETHICS, 2011, 32 (01) : 47 - 60
  • [7] Choosing a Patient-Reported Outcome Measure
    McClimans, Leah M.
    Browne, John P.
    [J]. QUALITY OF LIFE RESEARCH, 2010, 19 : 125 - 125
  • [8] Choosing a patient-reported outcome measure
    Leah M. McClimans
    John Browne
    [J]. Theoretical Medicine and Bioethics, 2011, 32 : 47 - 60
  • [9] THE COELIAC DISEASE ASSESSMENT QUESTIONNAIRE (CDAQ): DEVELOPMENT OF A PATIENT-REPORTED OUTCOME MEASURE
    Crocker, H.
    Jenkinson, C.
    Churchman, D.
    Peters, M.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A595 - A595
  • [10] The Vision Correction Questionnaire: an electronic patient-reported outcome measure for refractive surgery
    Frings, Andreas
    Ziaei, Mohammed
    Lundstrom, Mats
    Allan, Bruce D.
    [J]. JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2022, 48 (12): : 1427 - 1432